Default company panoramic image
Ffef4727 9d5c 4021 a31e c6719b787bad


Annually millions of patients suffer from Radiation Dermatitis with no treatment designated, Standard of Care. Ours will be that Standard.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Tampa, FL, USA
  • Currency USD
  • Founded January 1999
  • Employees 3

Company Summary

HydroGenesis manufactures, distributes and licenses products containing ALLENiCONE®, a new family of patented silicones. This technology allows for the TOUCHLESS delivery of silicone that promotes healing and pain relief of burns and wounds. Testimonials from Doctors and Patients claim incredible results where none were previously possible. A 4-6 month FDA market registration process will bring this treatment to millions of patients.


  • Default avatar
    Scott M Tappan
    Chief Executive Officer

    Mr. Tappan is an entrepreneurial, senior executive and investor with 20+ years demonstrated success across multiple industries. He has significant experience in leading multi-million dollar companies including startups, turnarounds and high growth companies. He has held executive positions in sales, operations, and supply chain; providing a unique insight into many facets of a company’s infrastructure. Mr. Tappan received his BSIE from USF.

  • Default avatar
    Jennifer R. Allen
    President, Board Chair

    Ms. Allen is a seasoned entrepreneur, successful business woman and co-founder of HydroGenesis. She has served on a number of healthcare related Boards and is very active with Hospice. Ms. Allen received her Bachelor’s degree from WilliamSmith College, holds her MSW from the University of New Hampshire, and attended Harvard & Episcopal Divinity Schools.

  • Default avatar
    William Leasure
    VP Sales & Marketing

    An accomplished senior executive, Mr. Leasure's 30 year tenure with IBM saw him in a number of high profile capacities. His work quickly vaulted him to become a recognized expert. After leading teams in new product development, market development, and sales, he worked to launch a new division of IBM which he helped grow to over $2.2B in worldwide sales. Earning his degree from Ohio University, Mr. Leasure is a decorated veteran and speaker.

  • Default avatar
    Leonard William Luria, MD
    Chief Scientific Officer

    Dr. Luria is a Board Certified Plastic and Reconstructive Surgeon and co-founder of HydroGenesis. He is a graduate of Hobart College with studies and research at Buffalo General, Mt. Sinai, and Brooke Army Hospitals. His 30 year research and work with Beta Labs and Scripps Clinical Laboratories led to the development of the patented Silicone, ALLENiCONE®.

  • Default avatar
    Robert Galloway
    Vice President

    Mr. Galloway has held management and executive positions in both investor owned and
    not-for-profit U.S. health care companies and institutions for over four decades. His
    experiences include the development of two U.S. public companies, Chairman and CEO, for two U.S. listed health care companies; Chief Financial Officer, for two academic medical centers and Health Maintenance Organizations; SVP Development, for Vanguard Health Systems, and HCA.


  • Default avatar
    Robert Grammig - Holland & Knigh
    Default avatar
    Alan Fisk - Crowe Horwath

Previous Investors

  • Default avatar
    Friends and family